2013-02-28 14:40:32 - SADIF-Investment Analytics has applied its StockMarks™ stock-rating system to produce reports on a company's attractiveness to long-term investors.

Ilhavo, Portugal — SADIF Investment Analytics, announces a new summary due diligence report covering the following companies:

Report Summary for: Xinjiang Tianfu Thermoelectric Co., Ltd is an average quality company with a neutral outlook. Xinjiang Tianfu Thermoelectric Co., Ltd has strong business growth and is run by passable management. The trend in Xinjiang Tianfu Thermoelectric Co., Ltd fair value exchange rate against its closest rated-competitor, Jiangxi Ganneng Co., Ltd, has been depreciating over the past 2 weeks. When compared to its closest competitor, Xinjiang Tianfu Thermoelectric Co., Ltd shows similar overvaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics

at:
www.sadifanalytics.com/stockmarks/company-21-600509

Report Summary for: Black Peony (Group) Co., Ltd is an average quality company with a neutral outlook. Black Peony (Group) Co., Ltd has medium business growth and is run by passable management. The trend in Black Peony (Group) Co., Ltd fair value exchange rate against its closest rated-competitor, Guangdong Xinhui Meida Nylon Co., Ltd., has been depreciating over the past 2 weeks. When compared to its closest competitor, Black Peony (Group) Co., Ltd shows similar undervaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-600510

Report Summary for: China National Medicines Corporation Ltd is an above average quality company with a positive outlook. China National Medicines Corporation Ltd has medium business growth and is run by efficient management. The trend in China National Medicines Corporation Ltd fair value exchange rate against its closest rated-competitor, Chongqing Tong Jun Ge Co.,Ltd, has been depreciating over the past 2 weeks. When compared to its closest competitor, China National Medicines Corporation Ltd shows similar overvaluation and is equally likely to outperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-600511

Report Summary for: Tengda Construction Group Co., Ltd. is a low quality company with a neutral outlook. Tengda Construction Group Co., Ltd. has weak business growth and is run by mediocre management. The trend in Tengda Construction Group Co., Ltd. fair value exchange rate against its closest rated-competitor, Tibet Tianlu Co., Ltd., has been depreciating over the past 2 weeks. When compared to its closest competitor, Tengda Construction Group Co., Ltd. shows similar overvaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-600512

Report Summary for: Jiangsu Lianhuan Pharmaceutical Co. Ltd is a below average quality company with a neutral outlook. Jiangsu Lianhuan Pharmaceutical Co. Ltd has medium business growth and is run by efficient management. The trend in Jiangsu Lianhuan Pharmaceutical Co. Ltd fair value exchange rate against its closest rated-competitor, Shanghai Furen Industrial (Group) Co., has been depreciating over the past 2 weeks. When compared to its closest competitor, Jiangsu Lianhuan Pharmaceutical Co. Ltd shows similar overvaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-600513

Report Summary for: Kangmei Pharmaceutical Co Ltd is an above average quality company with a neutral outlook. Kangmei Pharmaceutical Co Ltd has strong business growth and is run by efficient management. The trend in Kangmei Pharmaceutical Co Ltd fair value exchange rate against its closest rated-competitor, Yunnan Baiyao Group Co., Ltd, has been depreciating over the past 2 weeks. When compared to its closest competitor, Kangmei Pharmaceutical Co Ltd shows similar overvaluation and is equally likely to outperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-600518

Report Summary for: Kweichow Moutai Co., Ltd. is a high quality company with a positive outlook. Kweichow Moutai Co., Ltd. has strong business growth and is run by efficient management. The trend in Kweichow Moutai Co., Ltd. fair value exchange rate against its closest rated-competitor, Lu Zhou Lao Jiao Co.,Ltd, has been depreciating over the past 2 weeks. When compared to its closest competitor, Kweichow Moutai Co., Ltd. shows greater undervaluation and is equally likely to outperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-600519

Report Summary for: Tongling Trinity Technology Co.,Ltd. is an average quality company with a neutral outlook. Tongling Trinity Technology Co.,Ltd. has weak business growth and is run by mediocre management. The trend in Tongling Trinity Technology Co.,Ltd. fair value exchange rate against its closest rated-competitor, Sichuan Chengfei Integration Tech Corp, has been appreciating over the past 2 weeks. When compared to its closest competitor, Tongling Trinity Technology Co.,Ltd. shows similar overvaluation and is equally likely to outperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-600520

Report Summary for: Jiangsu Zhongtian Technologies Co., Ltd. is an average quality company with a negative outlook. Jiangsu Zhongtian Technologies Co., Ltd. has medium business growth and is run by efficient management. The trend in Jiangsu Zhongtian Technologies Co., Ltd. fair value exchange rate against its closest rated-competitor, Tongling Jingda Special Magnet Wire Co., has been depreciating over the past 2 weeks. When compared to its closest competitor, Jiangsu Zhongtian Technologies Co., Ltd. shows similar overvaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-600522

Report Summary for: Guizhou Guihang Automotive Components Co is an average quality company with a neutral outlook. Guizhou Guihang Automotive Components Co has medium business growth and is run by efficient management. The trend in Guizhou Guihang Automotive Components Co fair value exchange rate against its closest rated-competitor, Harbin Dongan Auto Engine Co., Ltd, has been depreciating over the past 2 weeks. When compared to its closest competitor, Guizhou Guihang Automotive Components Co shows similar undervaluation and is equally likely to outperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-600523

Report Summary for: Changyuan Group Ltd is an above average quality company with a neutral outlook. Changyuan Group Ltd has strong business growth and is run by efficient management. The trend in Changyuan Group Ltd fair value exchange rate against its closest rated-competitor, Huagong Tech Company Limited, has been depreciating over the past 2 weeks. When compared to its closest competitor, Changyuan Group Ltd shows similar overvaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-600525

Report Summary for: Zhejiang Feida Env. Sci & Tech Co Ltd is an average quality company with a positive outlook. Zhejiang Feida Env. Sci & Tech Co Ltd has weak business growth and is run by mediocre management. The trend in Zhejiang Feida Env. Sci & Tech Co Ltd fair value exchange rate against its closest rated-competitor, Xiamen Savings Environmental Co., Ltd, has been depreciating over the past 2 weeks. When compared to its closest competitor, Zhejiang Feida Env. Sci & Tech Co Ltd shows similar overvaluation and is equally likely to outperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-600526

Report Summary for: Jiangsu Jiangnan High Polymer Fiber is a high quality company with a neutral outlook. Jiangsu Jiangnan High Polymer Fiber has strong business growth and is run by efficient management. The trend in Jiangsu Jiangnan High Polymer Fiber fair value exchange rate against its closest rated-competitor, Sichuan Nitrocell Co., Ltd, has been depreciating over the past 2 weeks. When compared to its closest competitor, Jiangsu Jiangnan High Polymer Fiber shows similar undervaluation and is equally likely to outperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-600527

Report Summary for: China Railway Erju Co., Ltd. is a below average quality company with a neutral outlook. China Railway Erju Co., Ltd. has strong business growth and is run by mediocre management. The trend in China Railway Erju Co., Ltd. fair value exchange rate against its closest rated-competitor, East China Engineering Science & Tech Co, has been depreciating over the past 2 weeks. When compared to its closest competitor, China Railway Erju Co., Ltd. shows similar overvaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-600528

Report Summary for: Shandong Pharmaceutical Glass Co., Ltd is a low quality company with a negative outlook. Shandong Pharmaceutical Glass Co., Ltd has weak business growth and is run by passable management. The trend in Shandong Pharmaceutical Glass Co., Ltd fair value exchange rate against its closest rated-competitor, Jiangsu Yuyue Medical Equipment & Supply, has been depreciating over the past 2 weeks. When compared to its closest competitor, Shandong Pharmaceutical Glass Co., Ltd shows greater overvaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-600529

Report Summary for: Shanghai Jiaoda Onlly Co., Ltd is a below average quality company with a neutral outlook. Shanghai Jiaoda Onlly Co., Ltd has weak business growth and is run by efficient management. The trend in Shanghai Jiaoda Onlly Co., Ltd fair value exchange rate against its closest rated-competitor, Shanghai Met (Group) Corporation, has been depreciating over the past 2 weeks. When compared to its closest competitor, Shanghai Jiaoda Onlly Co., Ltd shows greater overvaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-600530

Report Summary for: Henan Yuguang Gold & Lead Co., Ltd is an above average quality company with a neutral outlook. Henan Yuguang Gold & Lead Co., Ltd has medium business growth and is run by mediocre management. The trend in Henan Yuguang Gold & Lead Co., Ltd fair value exchange rate against its closest rated-competitor, Tongling Nonferrous Metals Group Co Ltd, has been depreciating over the past 2 weeks. When compared to its closest competitor, Henan Yuguang Gold & Lead Co., Ltd shows similar undervaluation and is equally likely to outperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-600531

Report Summary for: Nanjing Chixia Development Co., Ltd is a below average quality company with a neutral outlook. Nanjing Chixia Development Co., Ltd has medium business growth and is run by efficient management. The trend in Nanjing Chixia Development Co., Ltd fair value exchange rate against its closest rated-competitor, Shenzhen Special Ecn Zn Rl Est Gr Co Ltd, has been depreciating over the past 2 weeks. When compared to its closest competitor, Nanjing Chixia Development Co., Ltd shows similar overvaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-600533

Report Summary for: Tasly Pharmaceutical Group Co Ltd is an above average quality company with a positive outlook. Tasly Pharmaceutical Group Co Ltd has strong business growth and is run by efficient management. The trend in Tasly Pharmaceutical Group Co Ltd fair value exchange rate against its closest rated-competitor, Guangzhou Pharmaceutical Company Limited, has been depreciating over the past 2 weeks. When compared to its closest competitor, Tasly Pharmaceutical Group Co Ltd shows similar overvaluation and is equally likely to outperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-600535

Report Summary for: China National Software & Service Co Ltd is a below average quality company with a negative outlook. China National Software & Service Co Ltd has weak business growth and is run by passable management. The trend in China National Software & Service Co Ltd fair value exchange rate against its closest rated-competitor, Anhui USTC iFlytek Co., Ltd., has been depreciating over the past 2 weeks. When compared to its closest competitor, China National Software & Service Co Ltd shows similar overvaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-600536

Report Summary for: Eging Photovoltaic Technology Co Ltd is an above average quality company with a neutral outlook. Eging Photovoltaic Technology Co Ltd has strong business growth and is run by inefficient management. The trend in Eging Photovoltaic Technology Co Ltd fair value exchange rate against its closest rated-competitor, Xinjiang Tecon Anml Hsbndry Bio Tchnlgy, has been depreciating over the past 2 weeks. When compared to its closest competitor, Eging Photovoltaic Technology Co Ltd shows similar overvaluation and is equally likely to outperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-600537

Report Summary for: Beihai Gofar Marine Biological Industry is an average quality company with a neutral outlook. Beihai Gofar Marine Biological Industry has medium business growth and is run by inefficient management. The trend in Beihai Gofar Marine Biological Industry fair value exchange rate against its closest rated-competitor, Anhui Huaxing Chemical Industry Co., Ltd, has been depreciating over the past 2 weeks. When compared to its closest competitor, Beihai Gofar Marine Biological Industry shows similar undervaluation and is equally likely to outperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-600538


About SADIF-Investment Analytics:
SADIF-Investment Analytics is an independent investment research company covering twenty four different markets and over 18,000 companies. The StockMarks™ system is based on proven investment principles and is designed to drive long-term shareholder returns.